234 related articles for article (PubMed ID: 31830504)
1. Discovering the structure-activity relationships of different O-prenylated coumarin derivatives as effective anticancer agents in human cervical cancer cells.
Maleki EH; Bahrami AR; Sadeghian H; Matin MM
Toxicol In Vitro; 2020 Mar; 63():104745. PubMed ID: 31830504
[TBL] [Abstract][Full Text] [Related]
2. Anticancer Properties of a New Hybrid Analog AD-013 Combining a Coumarin Scaffold with an α-methylene-δ-lactone Motif.
Dlugosz A; Gach-Janczak K; Szymanski J; Deredas D; Krawczyk H; Janecki T; Janecka A
Anticancer Agents Med Chem; 2018; 18(3):450-457. PubMed ID: 28933263
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and In Vitro Evaluation of Novel 3, 7-Disubstituted Coumarin Derivatives as Potent Anticancer Agents.
Wang Y; Liu H; Lu P; Mao R; Xue X; Fan C; She J
Chem Biol Drug Des; 2015 Oct; 86(4):637-47. PubMed ID: 25626768
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents.
Yan G; Luo J; Han X; Zhang W; Pu C; Zhou M; Zhong X; Hou X; Hou MZ; Li R
Anticancer Agents Med Chem; 2021; 21(17):2351-2367. PubMed ID: 33511941
[TBL] [Abstract][Full Text] [Related]
5. Investigating the Anti-tumor and Apoptosis-inducing Effects of Coumarin Derivatives as Potent 15-Lipoxygenase Inhibitors on PC-3 Prostate Cancer Cells.
Maleki F; Sadeghian H; Bahrami AR; Goftari SN; Matin MM
Anticancer Agents Med Chem; 2023; 23(15):1722-1730. PubMed ID: 37171011
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents.
Zhang W; Li Z; Zhou M; Wu F; Hou X; Luo H; Liu H; Han X; Yan G; Ding Z; Li R
Bioorg Med Chem Lett; 2014 Feb; 24(3):799-807. PubMed ID: 24418772
[TBL] [Abstract][Full Text] [Related]
7. In vitro investigation of anticancer, cell-cycle-inhibitory, and apoptosis-inducing effects of diversin, a natural prenylated coumarin, on bladder carcinoma cells.
Haghighitalab A; Matin MM; Bahrami AR; Iranshahi M; Saeinasab M; Haghighi F
Z Naturforsch C J Biosci; 2014; 69(3-4):99-109. PubMed ID: 24873030
[TBL] [Abstract][Full Text] [Related]
8. Some new indole-coumarin hybrids; Synthesis, anticancer and Bcl-2 docking studies.
Kamath PR; Sunil D; Ajees AA; Pai KS; Das S
Bioorg Chem; 2015 Dec; 63():101-9. PubMed ID: 26469742
[TBL] [Abstract][Full Text] [Related]
9. Recent Developments of Target Based Coumarin Derivatives as Potential Anticancer Agents.
Goud NS; Kumar P; Bharath RD
Mini Rev Med Chem; 2020; 20(17):1754-1766. PubMed ID: 32386492
[TBL] [Abstract][Full Text] [Related]
10. Benzothiazole derivatives bearing amide moiety: potential cytotoxic and apoptosis-inducing agents against cervical cancer.
Singh M; Modi A; Narayan G; Singh SK
Anticancer Drugs; 2016 Jul; 27(6):519-32. PubMed ID: 26945135
[TBL] [Abstract][Full Text] [Related]
11. Coumarin-containing hybrids and their anticancer activities.
Zhang L; Xu Z
Eur J Med Chem; 2019 Nov; 181():111587. PubMed ID: 31404864
[TBL] [Abstract][Full Text] [Related]
12. Recent developments of C-4 substituted coumarin derivatives as anticancer agents.
Dandriyal J; Singla R; Kumar M; Jaitak V
Eur J Med Chem; 2016 Aug; 119():141-68. PubMed ID: 27155469
[TBL] [Abstract][Full Text] [Related]
13. New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies.
Abd El-Karim SS; Syam YM; El Kerdawy AM; Abdelghany TM
Bioorg Chem; 2019 May; 86():80-96. PubMed ID: 30685646
[TBL] [Abstract][Full Text] [Related]
14. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.
Ma CC; Liu ZP
Anticancer Agents Med Chem; 2017; 17(3):395-403. PubMed ID: 26902599
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.
Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE
Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320
[TBL] [Abstract][Full Text] [Related]
16. New Coumarin Derivatives as Anti-Breast and Anti-Cervical Cancer Agents Targeting VEGFR-2 and p38α MAPK.
Batran RZ; Dawood DH; El-Seginy SA; Ali MM; Maher TJ; Gugnani KS; Rondon-Ortiz AN
Arch Pharm (Weinheim); 2017 Sep; 350(9):. PubMed ID: 28787092
[TBL] [Abstract][Full Text] [Related]
17. Synthetic Mono/di-halogenated Coumarin Derivatives and Their Anticancer Properties.
Kasumbwe K; Venugopala KN; Mohanlall V; Odhav B
Anticancer Agents Med Chem; 2017; 17(2):276-285. PubMed ID: 27671300
[TBL] [Abstract][Full Text] [Related]
18. Coumarin polysulfides inhibit cell growth and induce apoptosis in HCT116 colon cancer cells.
Saidu NE; Valente S; Bana E; Kirsch G; Bagrel D; Montenarh M
Bioorg Med Chem; 2012 Feb; 20(4):1584-93. PubMed ID: 22264758
[TBL] [Abstract][Full Text] [Related]
19. DNA-binding activity and cytotoxic and cell-cycle arrest properties of some new coumarin derivatives: a multispectral and computational investigation.
Khosravifar F; Dehghan G; Bidoki SK; Mahdavi M
Luminescence; 2020 Feb; 35(1):98-106. PubMed ID: 31475787
[TBL] [Abstract][Full Text] [Related]
20. Carvacrol Exhibits Chemopreventive Potential against Cervical Cancer Cells via Caspase-Dependent Apoptosis and Abrogation of Cell Cycle Progression.
Ahmad A; Ansari IA
Anticancer Agents Med Chem; 2021 Oct; 21(16):2224-2235. PubMed ID: 33390139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
